DARIFENACIN HYDROBROMIDE

DARIFENACIN HYDROBROMIDE

Stock Code: 3574475
Manufacturer Part No: SML1102-50MG
Order Now for 7 day delivery
£359.36 (exc VAT) per 50MG
Quantity: - +

Application


Darifenacin hydrobromide has been used to inject experimental animals.


Biochem/physiol Actions


Darifenacin hydrobromide is an antispasmodic muscarinic antagonist, selective for blocking the M3 muscarinic acetylcholine receptor.


Darifenacin hydrobromide is an antispasmodic muscarinic antagonist, selective for blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions. Darifenacin hydrobromide has 9 and 12-fold greater affinity for M3 compared to M1 and M5, respectively, and 59-fold greater affinity for M3 compared to both M2 and M4. Darifenacin is used clinically to treat urinary incontinence and overactive bladder syndrome.


Features and Benefits


This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.


General description


Darifenacin is a muscarinic receptor antagonist. It is an extended release tablet that has 7.5mg or 15mg darifenacin as its hydrobromide salt.


Packaging


10, 50 mg in glass bottle

Colourwhite to beige
Quality Level100
InChI keyUQAVIASOPREUIT-VQIWEWKSSA-N
InChI1S/C28H30N2O2.BrH/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26;/h1-12,19,25H,13-18,20H2,(H2,29,31);1H
ManufacturerSIGMA-ALDRICH
Formpowder
Assay≥98% (HPLC)

There are no downloads for this product.